3 unknown, 1 completed, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Chronic Active Epstein-Barr Virus Infection: new trials by email Literature Review of Chronic Active Epstein-Barr Virus Infection trials Research Report on Chronic Active Epstein-Barr Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders Umbilical cord blood transplantation as treatment of Epstein-Barr virus-associated lymphoproliferative diseases - Epstein-Barr Virus-associated Lymphoproliferative Diseases, Chronic Active Epstein-Barr Virus Infection | Phase 2 | Recruiting | Fudan University | 80 | 2026-01-01 | 2026-02-02 |
| Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT donor EBV-specific T lymphocytes - Chronic Active Epstein-Barr Virus Infection, Virus-Associated Hemophagocytic Syndrome | Not applicable | Unknown | Beijing Friendship Hospital | 15 | 2022-10-08 | 2023-06-27 |
| Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients No intervention - Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | Unknown | Beijing Friendship Hospital | 128 | 2022-10-01 | 2023-05-03 | |
| Rituximab Monotherapy for EBV-HLH and CAEBV Rituximab Monotherapy - Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | Phase 3 | Unknown | Beijing Friendship Hospital | 30 | 2022-02-01 | 2022-05-20 |
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) Hematopoietic Stem Cell Transplant - Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | Phase 2 | Completed | Medical College of Wisconsin | 47 | 2013-12-01 | 2022-12-08 |
Granulomatous Disease, Chronic (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Leukocyte adhesion deficiency type 1 (1) · Lymphohistiocytosis, Hemophagocytic (1)
Blood Protein Disorders (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Dysgammaglobulinemia (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Histiocytosis (1) · Histiocytosis, Non-Langerhans-Cell (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Leukocyte Disorders (1) · Lymphatic Diseases (1)
Beijing Friendship Hospital (3) · Fudan University (1) · Medical College of Wisconsin (1)
China (4) · Canada (1) · United States (1)
Jiexian Ma (1) · Mary Horowitz, MD, MS (1)
U10HL069294 (1), U24CA076518 (1)